Private
During the last week in April, the U.S. Department of Homeland Security (DHS) Science and Technology Directorate (S&T) and the Cybersecurity and Infrastructure Security Agency (CISA) hosted the JamX 22 exercise to further resilience to signal jamming threats for federal and first responders.... Read More »
FirstNet Authority Board has approved an investment to expand network coverage services through small-cell technologies, which would bolster FirstNet indoor operations.
The FirstNet Authority is an independent Department of Commerce National Telecommunications and Information Administration... Read More »
The Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health and Human Services, announced Tuesday it had partnered with a number of industry and academic organizations to advance next-gen diagnostics to detect respiratory viruses in a single test.... Read More »
The U.S. Air Force awarded Northrop Grumman Corporation a contract to prepare the AN/ALQ-257 Integrated Viper Electronic Warfare Suite (IVEWS) for developmental testing and hardware qualification.
IVEWS utilizes ultra-wideband architecture to provide instantaneous bandwidth needed to defeat... Read More »
BAE Systems officials are espousing the benefits of its newly opened engineering and production facility in Manchester, N.H., which will support electronic warfare (EW) systems development initiatives.
“Our new Manchester facility is critical to developing next-generation electromagnetic... Read More »
America’s largest shipbuilder HII announced Thursday it launched the Virginia-class submarine New Jersey into the James River at the company’s Newport News Shipbuilding Division.
The 7,800-ton submarine was submerged and moved by tugboats to the shipyard’s submarine pier for final... Read More »
The U.S. Department of Homeland Security (DHS) Science and Technology Directorate (S&T) National Urban Security Technology Laboratory (NUSTL) recently issued a vehicle extrication tools request for information (RFI).
The agency is seeking commercially available vehicle extrication tools... Read More »
As part of Biomedical Advanced Research and Development Authority’s (BARDA) Beyond the Needle program, Lumen Bioscience is working to create a new antibody cocktail for treatment of SARS-CoV-2, delivered intranasally.
Beyond the Needle, managed by the Division of Research Innovation and... Read More »
A Lyme disease vaccine candidate for adults and children at least 5 years old produced strong immunogenicity, safety and overall positive results this week in a Phase 2 trial conducted by its developers, Valneva SE and Pfizer Inc.
This marked the first clinical study where VLA15, as the... Read More »
Navy officials said the service branch has awarded a $483 million contract with options to Raytheon Missiles & Defense to complete Zumwalt-class destroyers activation and fleet introduction.
If exercised, the agreement will total $1.68 billion across five years while continuing to develop... Read More »
While adding Paxlovid – nirmatrelvir and ritonavir – to its list of recommended treatments for mild and moderate COVID-19 patients at risk of hospital admission, the World Health Organization (WHO) noted that lack of price transparency at Pfizer Inc. and testing demands before administration... Read More »
Encouraged by the Department of Homeland Security (DHS), more than 450 vetted security researchers and ethical hackers rooted through select external DHS systems and turned up 122 vulnerabilities, earning a cash prize for their efforts.
The first phase of the Hack DHS buck hunting program... Read More »
Engineering, construction, and project management firm Bechtel recently detailed the elimination of the last U.S. chemical weapon containing VX nerve agent.
The action was executed at the Bechtel-led Blue Grass Chemical Agent-Destruction Pilot Plant (BGCAPP) near Richmond, Kentucky, marking... Read More »
A global, Phase 3 trial of approximately 20,000 older adult volunteers for the Bavarian Nordic A/S MVA-BN RSV vaccine candidate began this week and is expected to produce results by mid-2023.
The randomized, double-blind test will gather those aged 60 years and older in both the United States... Read More »
A joint cybersecurity advisory was issued this week by a collection of various U.S. intelligence and security agencies, as well as international partners, providing a comprehensive overview of Russian state-sponsored and criminal cyber threats to critical infrastructure.
This focus on Russia... Read More »
New clinical data from Moderna, Inc. this week showed that a month after using a bivalent COVID-19 booster candidate, mRNA-1273.211, superior vaccination efficacy was maintained against all variants of concern, including Beta, Delta, and Omicron.
These results stemmed from 50 µg booster doses,... Read More »
The National Security Agency (NSA) held its annual three-day NSA Cyber Exercise (NCX) earlier this month, gathering participants from various military academies, universities, and more to develop and test their cybersecurity skills.
While the U.S. Air Force Academy was crowned the winner of the... Read More »
The U.S. Army has awarded science, technology, and engineering solutions firm KBR a $62 million, five-year recompete task order to provide conception-to-completion development, testing, engineering, and analysis services.
KBR would execute duties to aid the U.S. Army Program Executive Office... Read More »
Utilizing its synthetic, CD8+ T cell Adaptive Vaccine platform, Emergex Vaccines Holding Ltd. began preclinical development last week of a new medical countermeasure against tularemia.
Tularemia is caused by francisella tularensis, an exceptionally virulent intracellular bacterial pathogen. The... Read More »
Due to discussions between the U.S. Food and Drug Administration (FDA) and Regeneron Pharmaceuticals, Inc. over pre-exposure prophylactic use, the FDA will extend the review of a Biologics License Application (BLA) for REGEN-COV as a COVID-19 treatment for three months.
Regeneron seeks to use... Read More »
A new avenue of testing for COVID-19 opened last week, with emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the InspectIR COVID-19 Breathalyzer, a diagnostic capable of detecting SARS-CoV-2 infection from breath samples.
In less than three minutes, the... Read More »
Northrop Grumman Corporation officials said the technology company has initiated construction on a new facility supporting Kirtland Air Force Base and military customers in Albuquerque, N.M.
The company said the 25,000-square-foot site is slated to open in early 2023 to support national security... Read More »
The Defense Advanced Research Projects Agency (DARPA) recently detailed the second successful flight test of the Lockheed Martin Hypersonic Air-breathing Weapon Concept (HAWC).
"This Lockheed Martin HAWC flight test successfully demonstrated a second design that will allow our warfighters to... Read More »
Japan’s NEC Corporation gained seed funding of up to $4.8 million from the Coalition for Epidemic Preparedness Innovation (CEPI) this week to help its Norway-based subsidiary with the initial development of broadly protective betacoronavirus vaccine candidates.
NEC OncoImmunity AS (NOI)... Read More »
Threat detection and security screening technologies firm Smiths Detection said it has launched iCMORE Currency, a new automated detection algorithm currency recognition software.
“We are very pleased to announce iCMORE Currency, the latest round of enhancements for our HI-SCAN series," Smiths... Read More »
The National Institute of Allergy and Infectious Diseases (NIAID) this week awarded four grants totaling approximately $4.3 million of investment over the first year alone to launch new Tuberculosis Research Advancement Centers (TRACs) across the country.
These grants will last five years,... Read More »
A Phase 3 clinical trial of Vaxxinity, Inc.’s UB-612 heterologous COVID-19 vaccine booster dose candidate gained up to $9.25 million in support from the Coalition for Epidemic Preparedness Innovation (CEPI) this week to help evaluate the candidate’s abilities.
“As we strive to stay one... Read More »
Lockheed Martin and Intel Corporation recently announced the expansion of an ongoing strategic relationship to provide U.S. Department of Defense (DOD) 5G-enabled hardware and software solutions.
The memorandum of understanding (MOU) signed late last year would enable faster and more decisive... Read More »
A supplemental Biologics License Application (sBLA) for Roche’s Actemra/RoActemra intravenous treatment for COVID-19 cases among hospitalized patients was accepted by the United States Food and Drug Administration (FDA) this week and will benefit from priority review.
If approved, the drug... Read More »
U.S. Sen. Marco Rubio (R-FL) forwarded correspondence to Apple CEO Tim Cook, expressing his concern regarding reports that the company is considering purchasing NAND chips from a Chinese manufacturer.
Rubio maintains Yangtze Memory Technologies Co. (YMTC) serves as a company with links to the... Read More »
The Navy has selected Huntington Ingalls Industries (HII) to produce and test its REMUS 300 craft as the branch's next-generation small unmanned underwater vehicle (SUUV) program of record.
“HII is proud of our longstanding partnership with the U.S. Navy and now, to lead in this important... Read More »
Threat detection and security screening technology firm Smiths Detection has been selected to supply 47 CTX 9800 DSi explosive detection systems to the Transport Security Administration (TSA).
“We are delighted to announce this new order to supply our CTX 9800 DSi systems, which highlights... Read More »
Members of the Organisation for the Prohibition of Chemical Weapons (OPCW) Executive Council attended a meeting in The Hague last week to assess the progress of chemical weapons destruction efforts in the United States as they hone in on completion.
As a matter of demilitarization transparency,... Read More »
Northrop Grumman Corporation officials recently unveiled the company's newest building in Longbow Park in Boulder, Colo.
The effort supports the company's national security program, including the growth of the Overhead Persistent Infrared Exploitation (OPIR) and Advanced Mission Systems (AMS)... Read More »
Interim data emerged this week from a Phase 2/3 trial of Moderna, Inc.’s mRNA-1273 COVID-19 vaccine on children between 6 months and 6 years old, demonstrating efficacy similar to usage on adults and with a generally well-tolerated profile.
The KidCOVE trial provided participants with two 25... Read More »
